Pharmacokinetic, Efficacy, and Safety Study of Octafibrin Compared to Haemocomplettan/Riastap
Learn more about:
Related Clinical Trial
Pharmacokinetic Model of Fibrinogen Plasma Levels After Fibrinogen Administration
FIB Grifols Congenital Deficiency for On-demand Treatment and Surgical Prophylaxis
Patient Blood Management for Massive Obstetric Hemorrhage
Pharmacokinetics, Efficacy, and Safety of Human Plasma-Derived Fibrinogen (FIB Grifols) in Patients With Congenital Afibrinogenemia
Early Administration of Fibrinogen in Polytraumatized Patients With Hypofibrinogenemia: a Randomized Feasibility Trial
Study to Assess the Efficacy, Safety and Pharmacokinetic of Octafibrin in Paediatric Subjects With Fibrinogen Deficiency
Human Fibrinogen – Pharmacokinetics
An Observational Cohort Study of the Safety and Efficacy of Fibrinogen Concentrate, Human (FCH) in Subjects With Congenital Fibrinogen Deficiency
Fibrinogen Concentrate (Human) − Efficacy and Safety Study
Pharmacokinetic, Efficacy, and Safety Study of Octafibrin Compared to Haemocomplettan/Riastap
Efficacy and Safety Study of Octafibrin for On-demand Treatment of Acute Bleeding and to Prevent Bleeding During and After Surgery
Safety and Efficacy of Fibryga in Congenital Fibrinogen Deficiency
Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency